Prelude Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-45,404
Closed -$9.63M – 1459
2023
Q3
$9.63M Buy
45,404
+11,814
+35% +$2.36M 0.63% 21
2023
Q2
$6.46M Buy
33,590
+12,072
+56% +$2.4M 0.42% 30
2023
Q1
$4.36M Buy
21,518
+19,759
+1,123% +$3.17M 0.26% 76
2022
Q4
$226K Sell
1,759
-7,037
-80% -$908K 0.01% 916
2022
Q3
$1.2M Sell
8,796
-2,351
-21% -$383K 0.04% 366
2022
Q2
$1.97M Buy
+11,147
New +$1.61M 0.06% 305
2021
Q2
– Sell
-2,140
Closed -$297K – 2060
2021
Q1
$297K Buy
+2,140
New +$345K 0.01% 1155
2020
Q3
– Sell
-556
Closed -$94K – 2487
2020
Q2
$94K Sell
556
-232
-29% -$34.6K 0.01% 977
2020
Q1
$91K Sell
788
-4,752
-86% -$526K 0.01% 622
2019
Q4
$633K Sell
5,540
-745
-12% -$79K 0.02% 498
2019
Q3
$537K Buy
+6,285
New +$461K 0.02% 499
2019
Q2
– Sell
-323
Closed -$24K – 2243
2019
Q1
$24K Buy
+323
New +$23K ﹤0.01% 1288
2018
Q1
– Sell
-294
Closed -$16K – 1773
2017
Q4
$16K Buy
+294
New +$17.2K ﹤0.01% 1166
2017
Q3
– Sell
-4,135
Closed -$214K – 1963
2017
Q2
$214K Buy
4,135
+470
+13% +$29.9K 0.02% 555
2017
Q1
$230K Buy
3,665
+875
+31% +$54.6K 0.02% 522
2016
Q4
$147K Buy
2,790
+2,135
+326% +$128K 0.02% 689
2016
Q3
$35K Sell
655
-48
-7% -$2.28K ﹤0.01% 1166
2016
Q2
$28K Sell
703
-4,861
-87% -$185K ﹤0.01% 1178
2016
Q1
$195K Sell
5,564
-7,660
-58% -$257K 0.03% 563
2015
Q4
$593K Buy
13,224
+3,469
+36% +$144K 0.09% 242
2015
Q3
$376K Sell
9,755
-786
-7% -$35.4K 0.05% 354
2015
Q2
$510K Sell
10,541
-2,230
-17% -$92K 0.07% 304
2015
Q1
$451K Buy
12,771
+4,358
+52% +$149K 0.06% 375
2014
Q4
$270K Buy
+8,413
New +$293K 0.04% 533
2014
Q2
– Sell
-12,042
Closed -$549K – 2230
2014
Q1
$549K Buy
12,042
+4,625
+62% +$221K 0.07% 366
2013
Q4
$296K Buy
7,417
+900
+14% +$36.7K 0.05% 507
2013
Q3
$286K Sell
6,517
-9,839
-60% -$410K 0.05% 431
2013
Q2
$515K Buy
+16,356
New +$571K 0.11% 247

Other funds holding SGEN

Prelude Capital Management's SGEN Position: Q4 2023 in Review

Prelude Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 45,404 shares — an estimated $9.63M sold.

Prelude Capital Management first reported a position in SGEN in Q2 2013 and held it in 28 quarters. The position peaked at $9.63M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Prelude Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 45,404 Seagen Inc. Common Stock shares in Q4 2023, an estimated $9.63M.
  • Prelude Capital Management first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 28 quarters.
  • Prelude Capital Management's Seagen Inc. Common Stock position peaked at $9.63M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.